Ghosh N - Search Results

1

Can plasma prolactin predict tamoxifen resistance in patients with advanced breast cancer?

Bhatavdekar JM, Patel DD, Karelia NH, Shah NG, Ghosh N, Vora HH, Suthar TP, Balar DB, Doctor SS. Bhatavdekar JM, et al. Among authors: ghosh n. Eur J Surg Oncol. 1994 Apr;20(2):118-21. Eur J Surg Oncol. 1994. PMID: 8181575

2

Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.

Bhatavdekar JM, Patel DD, Shah NG, Giri DD, Vora HH, Karelia NH, Trivedi SN, Ghosh N, Suthar TP. Bhatavdekar JM, et al. Among authors: ghosh n. Neoplasma. 1992;39(1):39-42. Neoplasma. 1992. PMID: 1388248

3

Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectum.

Bhatavdekar JM, Patel DD, Giri DD, Karelia NH, Vora HH, Ghosh N, Shah NG, Trivedi SN, Balar DB. Bhatavdekar JM, et al. Among authors: ghosh n. Br J Cancer. 1992 Nov;66(5):977-80. doi: 10.1038/bjc.1992.395. Br J Cancer. 1992. PMID: 1419646 Free PMC article.

4

Estrogen and progesterone receptor status of primary breast cancer: relationship with the pattern of first metastasis and survival.

Bhatavdekar JM, Patel DD, Karelia NH, Trivedi SN, Shah NG, Vora HH, Ghosh N, Balar DB. Bhatavdekar JM, et al. Among authors: ghosh n. Neoplasma. 1992;39(6):349-52. Neoplasma. 1992. PMID: 1491724

5

Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifen.

Bhatavdekar JM, Shah NG, Patel DD, Karelia NH, Trivedi SN, Vora HH, Ghosh N, Giri DD, Balar DB. Bhatavdekar JM, et al. Among authors: ghosh n. Neoplasma. 1992;39(2):123-7. Neoplasma. 1992. PMID: 1528310

6

Plasma prolactin as an indicator of disease progression in advanced breast cancer.

Bhatavdekar JM, Shah NG, Balar DB, Patel DD, Bhaduri A, Trivedi SN, Karelia NH, Ghosh N, Shukla MK, Giri DD. Bhatavdekar JM, et al. Among authors: ghosh n. Cancer. 1990 May 1;65(9):2028-32. doi: 10.1002/1097-0142(19900501)65:9<2028::aid-cncr2820650924>3.0.co;2-9. Cancer. 1990. PMID: 2372769

7

Comparison of prolactin, CA 15-3 and TPA in breast carcinomas.

Bhatavdekar JM, Trivedi SN, Shah NG, Patel DD, Karelia NH, Shukla MK, Ghosh N, Vora HH. Bhatavdekar JM, et al. Among authors: ghosh n. Int J Biol Markers. 1989 Jul-Sep;4(3):150-6. doi: 10.1177/172460088900400304. Int J Biol Markers. 1989. PMID: 2614083

8

Prognosis in breast carcinoma utilizing plasma carcinoembryonic antigen and histologic characteristics of the primary tumor.

Bhatavdekar JM, Balar DB, Shah NG, Trivedi SN, Bhaduri A, Patel DD, Karelia NH, Shukla MK, Ghosh N. Bhatavdekar JM, et al. Among authors: ghosh n. Tumour Biol. 1987;8(5):233-40. doi: 10.1159/000217527. Tumour Biol. 1987. PMID: 3448770

9

Prognostic value of insulin-like growth factor-1 receptors in patients with colon/rectal cancer: correlation with plasma prolactin.

Bhatavdekar JM, Patel DD, Shah NG, Karelia NH, Vora HH, Ghosh N, Suthar TP, Balar DB. Bhatavdekar JM, et al. Among authors: ghosh n. Eur J Surg Oncol. 1995 Feb;21(1):23-6. doi: 10.1016/s0748-7983(05)80062-9. Eur J Surg Oncol. 1995. PMID: 7851547

10

Prolactin: its role in advanced tongue cancer.

Bhatavdekar JM, Patel DD, Vora HH, Shah NG, Karelia NH, Ghosh N, Balar DB. Bhatavdekar JM, et al. Among authors: ghosh n. J Surg Oncol. 1994 Oct;57(2):115-20. doi: 10.1002/jso.2930570209. J Surg Oncol. 1994. PMID: 7934062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

951 results

Search Page

Filters